🇺🇸 FDA

Intelligence Platform

Patents

Browse 169 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7812117

Vasostatin as marrow protectant

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7807640

Orally administered peptides synergize statin activity

The Regents of the University of California · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7777034

Crystalline ammonium salts of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7741482

Reference standard for characterization of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7709643

Synthesis of sodium narcistatin and related compounds

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7705188

Structural modification of resveratrol: sodium resverastatin phosphate

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7692010

Reference standard for characterization of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7692009

Reference standard for characterization of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7692008

Reference standard for characterization of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7687642

Fluvastatin sodium crystal forms, processes for preparing them, compositions containing th

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7674923

Process for preparing forms of atorvastatin calcium substantially free of impurities

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7612203

Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the prepa

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7582759

Diastereomeric purification of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7557096

Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7547686

Combretastatin A-3 prodrug

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541346

Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7538136

Crystalline forms of atorvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7531514

Orally administered peptides synergize statin activity

The Regents of the University of California · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7501450

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7488750

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7488480

Use of passive myostatin immunization in egg laying vertebrates

Regents of the University of Minnesota · Granted Tue Feb 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7468444

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7462609

Narcistatin prodrugs

THE ARIZONA BOARD OF REGENTS · Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7456297

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted